Evidence-based
We rely on verified sources and build formulations supported by validated scientific findings.
Welcome to the Creative Product Lab
Imbued with science.
We believe that innovation is a valuable new offering, which has to be precisely calculated.
Discuss a projectFrom ideation to development, production, design and market launch.
End-to-end development and launch of health products
Formulation as an art
Customised formulation solutions to grow your business, with feasibility, costs, and commercial potential assessed before any investment begins.
From idea to shelf
From ideation and formulation through to launch and lifecycle optimisation.
How we work
Nine steps from the first idea to the first commercial batch.
Idea & product goal analysis
We work out what problem the product solves and for whom. We fix the target effect, the dosage form and the limits on budget and production. The result is a short but unambiguous brief for what exactly we are developing.
Market & competitor research
We analyse the market, shelf landscape, competitors, consumer experience and safety signals. We combine IQVIA and DSM Group data with a specialised AI-powered analytics tool that evaluates pharmacovigilance data, safety signals and real-world product feedback from customers and patients. This gives you a comprehensive and up-to-date view of the category.
Business case
We build P&L and NPV models, optimise COGS, and analyse financial metrics and launch KPIs for your niche. We assess break-even potential, unit economics and key risks before the start of investment.
Formulation development that sets you apart
A detailed market analysis helps us find a marketing insight: an unmet need in your niche that our solution addresses. We then create formulas you won’t find with competitors: we select active and auxiliary ingredients, dosages, delivery and administration forms, and assess ingredient compatibility, so your product stands out instead of repeating what’s already on the market. Non-standard solutions remain compliant with regulatory requirements.
Design engineering
We develop packaging and design at every stage, in both digital and physical form. Form factor, organoleptic properties and design are built in alongside the formulation, not added after it.
Sourcing
We integrate product development, raw-material sourcing, regulatory-route confirmation, and manufacturing-site selection into one practical plan, assessing ingredients and suppliers for formulation fit, quality documentation, regulatory suitability, commercial terms, and supply-chain risks, while identifying production partners with the right technical capabilities, quality standards, capacity, and experience for your product category and dosage form.
Regulatory & claims
We assess the product category, composition limits, and permissible claims. We build the scientific rationale, formulate compliant product claims, and help prepare technical documentation. We also advise on relevant quality certifications and on the certificates, marks, and quality statements that can be presented on the packaging, ensuring they are properly substantiated and aligned with the product’s regulatory framework.
Development
We turn the approved product concept into a market-ready solution by coordinating formulation implementation, pilot batches, scale-up, and product testing. Depending on the product category, intended claims, and regulatory pathway, we organise the required laboratory studies and, where applicable, clinical testing, while managing technical documentation and registration throughout the process. This ensures that the final product meets defined quality, safety, performance, and compliance requirements before market entry.
Launch support
We coordinate the final steps from approved development to the first commercial batch. We create the launch roadmap, align all project stages and stakeholders, and prepare a complete production brief. We maintain document control across specifications, artwork, quality documentation, and approvals, ensuring a smooth transfer to commercial production and the successful release of your first market-ready batch.
1 / 9
Our values
One of our team’s key principles is that we do not use pre-existing State Registration Certificates (SGRs) or copy competitor products.
Each formulation is developed as an original solution, supported by its own regulatory pathway, product rationale, and evidence base.
Product Development Scope
Our expertise spans therapeutic areas, molecular modalities, and formulation platforms. We combine them to create science-led products tailored to the target, regulatory route, and market opportunity.
Product Focus Areas
- Mental wellbeing & cognitive performance
- Immunity, inflammation & gut health
- Dermocosmetics, skin health & nutricosmetics
- Women’s and men’s health
- Metabolic health & weight management
- Mobility, performance & recovery
- Regenerative medicine & healthy longevity
Molecular Modalities
- Small molecules
- Peptides & bioactive compounds
- Botanical extracts & galenic preparations
- Biologics, proteins & enzymes
- Nucleotide-based approaches
Routes of Administration & Dosage Forms
- Oral solid dosage forms
- Liquid formulations
- Topical & dermocosmetic formulations
- Modified-release systems
- Targeted delivery systems
- Inhalation & aerosol delivery
- Novel delivery formats
We work with products of different complexity levels
Select a category to see its complexity, market, registration timeline and product lifecycle.
Cosmetics & personal care
Level 1 of 4
Market
Crowded marketMany players on the market, so it is hard to compete without a clear point of difference.
Example
A neurocosmeceutical line: cream, serum and lotion with anti-inflammatory ingredients.
Registration
Declaration of conformity (DoC): up to 14 working days.
State registration certificate (SGR): up to 60 calendar days.
Product lifecycle
28 to 48 weeks
Food products
Level 1 of 4
Market
Crowded marketMany players on the market, so it is hard to compete without a clear point of difference.
Example
A functional bar or drink with adaptogens and plant extracts for the “energy & performance” category.
Registration
Declaration of conformity under TR CU 021/2011: from 3 to 15 working days, depending on the declaration scheme (batch or serial production) and the scope of laboratory testing.
Product lifecycle
28 to 48 weeks
Dietary supplements
Level 2 of 4
Market
Growing marketHigh organic growth (13% in 2025, forecast +15% in 2026), rising competition and tighter control of claims.
Example
A magnesium and adaptogen complex for the “anti-stress & sleep” category with an evidence base for dosages.
Registration
Obtaining an SGR from Rospotrebnadzor takes 4 to 6 months on average; timelines can be shortened by registering through other EAEU countries.
Product lifecycle
28 to 48 weeks
Medical devices
Level 3 of 4
Market
Open nicheHigh barriers to entry, strong margins, and customer loyalty after launch. For businesses prepared for a long development cycle.
Example
A device for home health monitoring, for example a test system or a simple-function instrument that needs no clinical trials involving humans.
Registration
Without clinical trials involving humans: statutory term up to 31 working days; in practice 10 to 12 months including the preparatory stage and entry in the register.
With clinical trials involving humans and Roszdravnadzor approval: statutory term up to 50 working days; the real term, depending on the risk class, is 18 to 24 months.
Product lifecycle
52 to 104 weeks (12 to 24 months)
Medicines
Level 4 of 4
Market
Long development cycles and strict regulatory requirements. Strong opportunities lie in differentiated generics, hybrid medicines, and biosimilars with a clear clinical or technological advantage.
Example
A novel inhalation delivery system for established anti-tuberculosis APIs, engineered to enable targeted deposition in the distal lung, including the alveolar region.
Registration
Generic registration: a bioequivalence study in Russia or the EAEU is mandatory; total statutory term 210 working days.
Original drug registration: a clinical study in Russia is mandatory; from 210 working days and longer, depending on the length of the trial.
Product lifecycle
156 to 260 weeks (3 to 5 years)
Timelines are indicative and apply across the Eurasian Economic Union (EAEU). They are not a guarantee of registration.
Daria Buklesheva
CEO & Founder
Experience & background
- 12+years of industry experience in innovation and business development
- 100+formulations in the portfolio
- 20+SKUs launched in the Russian and CIS markets
- BiotechInbio
- FMCGSplat Global
- PharmaBayer, STADA
- Petrochemicals & gas processingSIBUR
Scientific background
- Lomonosov Moscow State University, Faculty of Fundamental Medicine, and Skoltech, Biophotonics Lab
- Lecturer, MSU Faculty of Economics
- Course “Biotechnology Business”, Master’s in Innovation Management
- Top 5 Management courses of the 2024/25 academic year Source
Recognition
Award winner at Intel ISEF and Falling Walls Lab.
Contacts
We reply within 1 business day. Tell us about the project and we will propose the optimal route to launch.
imbeon Product Lab provides product development services. We do not guarantee registration and do not promise a therapeutic effect. We help prepare the product and reduce the risks of bringing it to market.